Myosmine

Suppliers

Names

[ CAS No. ]:
532-12-7

[ Name ]:
Myosmine

[Synonym ]:
Prestwick_202
3-(4,5-dihydro-3H-pyrrol-2-yl)-pyridine
Pyridine, 3-(1-pyrrolin-2-yl)-
dehydronornicotine
3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine
Pyridine, 3-(3,4-dihydro-2H-pyrrol-5-yl)-
MFCD00052019
3-(1-Pyrrolin-2-yl)pyridine
Myosmine
Pyridine,3-(3,4-dihydro-2H-pyrrol-5-yl)

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
244.7±22.0 °C at 760 mmHg

[ Melting Point ]:
42-44°C

[ Molecular Formula ]:
C9H10N2

[ Molecular Weight ]:
146.189

[ Flash Point ]:
101.8±22.3 °C

[ Exact Mass ]:
146.084396

[ PSA ]:
25.25000

[ LogP ]:
-0.63

[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C

[ Index of Refraction ]:
1.611

[ Storage condition ]:
2-8°C

[ Stability ]:
Moisture, Temperature Sensitive

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UT7660000
CHEMICAL NAME :
Pyridine, 3-(1-pyrrolin-2-yl)-
CAS REGISTRY NUMBER :
532-12-7
BEILSTEIN REFERENCE NO. :
0119254
LAST UPDATED :
199709
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C9-H10-N2
MOLECULAR WEIGHT :
146.21
WISWESSER LINE NOTATION :
T6NJ C- BT5N AUTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1875 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 63,423,1946
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
190 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 63,423,1946

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R22

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
UT7660000

[ HS Code ]:
2933990090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Methyl nicotinate
  • 4-oxo-4-pyridin-3-yl-butanenitrile
  • Pyrrolidine
  • 3-Iodopyridine
  • (±)-nicotine
  • 3-Vinyl-2-pyrrolidinone
  • Ethyl nicotinate
  • 1-(3-pyridyl)cyclobutanol

DownStream

  • 4-Hydroxy-1-(Pyridin-3-Yl)Butan-1-One
  • rac N'-Nitrosonornicotine
  • (±)-Nornicotine
  • 4-piperidin-3-ylbutan-1-amine
  • (±)-nicotine
  • L-Nicotine
  • (+)-Nicotine
  • 4-pyridin-3-ylbutan-1-amine

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

A reversed-phase HPLC-UV method developed and validated for simultaneous quantification of six alkaloids from Nicotiana spp.

J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 997 , 142-5, (2015)

A reversed-phase HPLC-UV method was developed, optimized, and validated for the separation and quantitation of six target alkaloids from leaves of Nicotiana species (nicotine, nornicotine, anatabine, ...

Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats.

Drug Alcohol Depend. 153 , 330-4, (2015)

While nicotine is the primary addictive compound in tobacco, other tobacco constituents including minor alkaloids (e.g., nornicotine, anabasine) may also contribute to tobacco addiction by mimicking o...

Low-dose nicotine self-administration is reduced in adult male rats naïve to high doses of nicotine: implications for nicotine product standards.

Exp. Clin. Psychopharmacol. 22(5) , 453-9, (2014)

Product standards that greatly reduce the content of nicotine within cigarettes may result in improved public health. The study presented here used an animal model to investigate whether individuals w...


More Articles

Related Compounds

  • o-Myosmine
  • 2-Methyl Myosmine
  • (+/-)-Isomyosmine
  • 6-Methyl Myosmine
  • Myosmine-2,4,5,6-d4
  • 6-Hydroxy-N-methyl Myosmine
  • 1-(1-Methyl-1H-pyrazol-4-yl)-cyclobutanecarboxylic acid ethyl ester
  • (S)-4-Amino-4-pyridin-4-yl-butyric acid ethyl ester
  • (R)-4-Amino-4-pyridin-4-yl-butyric acid ethyl ester
  • (S)-4-Amino-4-pyridin-3-yl-butyric acid ethyl ester
  • (R)-4-Amino-4-pyridin-4-yl-butyric acid tert-butyl ester
  • 3-tert-Butoxycarbonylamino-5-fluoro-pyridine-2-carboxylic acid methyl ester
  • (S)-2-(5-Chloro-pyridin-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester
  • (R)-2-(5-Chloro-pyridin-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester
  • Ethyl 2-bromoimidazo[1,2-a]pyrazine-5-carboxylate
  • 2,4-Dichloro-5-(toluene-4-sulfonyl)-5H-pyrrolo[3,2-d]pyrimidine-6-carboxylic acid ethyl ester
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.